X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1842) 1842
science & technology (1358) 1358
life sciences & biomedicine (1349) 1349
antifibrinolytic agents - therapeutic use (1079) 1079
female (1001) 1001
male (869) 869
middle aged (644) 644
antifibrinolytic agents - administration & dosage (628) 628
tranexamic acid - therapeutic use (587) 587
antifibrinolytic agents - adverse effects (579) 579
aged (560) 560
tranexamic acid (550) 550
blood loss, surgical - prevention & control (497) 497
tranexamic acid - administration & dosage (466) 466
adult (465) 465
treatment outcome (453) 453
surgery (411) 411
tranexamic acid - adverse effects (372) 372
abridged index medicus (350) 350
blood transfusion (328) 328
postoperative hemorrhage - prevention & control (257) 257
orthopedics (247) 247
prospective studies (234) 234
retrospective studies (224) 224
cardiovascular system & cardiology (210) 210
general & internal medicine (199) 199
double-blind method (186) 186
antifibrinolytic agents (175) 175
anesthesiology (172) 172
risk factors (172) 172
aged, 80 and over (167) 167
blood loss (165) 165
hematology (164) 164
medicine, general & internal (161) 161
arthroplasty, replacement, knee - adverse effects (153) 153
anticoagulants - adverse effects (149) 149
adolescent (148) 148
hemorrhage (147) 147
randomized controlled trials as topic (147) 147
cardiac & cardiovascular systems (141) 141
analysis (134) 134
health aspects (129) 129
postoperative hemorrhage - etiology (126) 126
medicine & public health (125) 125
time factors (123) 123
blood transfusion - statistics & numerical data (122) 122
antifibrinolytic agents - pharmacology (121) 121
hemorrhage - drug therapy (120) 120
mortality (120) 120
peripheral vascular disease (116) 116
aprotinin - therapeutic use (115) 115
administration, topical (114) 114
young adult (112) 112
acids (110) 110
administration, oral (110) 110
fibrinolysis (109) 109
child (106) 106
clinical trials (106) 106
aminocaproic acid - therapeutic use (103) 103
aprotinin - adverse effects (103) 103
thromboembolism (102) 102
drug therapy (101) 101
hemostatics - therapeutic use (101) 101
administration, intravenous (100) 100
animals (97) 97
bleeding (97) 97
dosage and administration (96) 96
care and treatment (95) 95
dose-response relationship, drug (94) 94
respiratory system (94) 94
pregnancy (93) 93
hemoglobin (92) 92
hemorrhage - etiology (92) 92
patients (91) 91
hemorrhage - prevention & control (89) 89
research (87) 87
anticoagulants (85) 85
arthroplasty, replacement, hip - adverse effects (85) 85
meta-analysis (84) 84
transfusion (84) 84
neurosciences & neurology (80) 80
antifibrinolytics (79) 79
clinical neurology (79) 79
coronary artery bypass (78) 78
pharmacology & pharmacy (78) 78
total knee arthroplasty (78) 78
usage (78) 78
aminocaproic acid - adverse effects (76) 76
warfarin - adverse effects (75) 75
anticoagulants - therapeutic use (74) 74
cardiopulmonary bypass (74) 74
obstetrics & gynecology (73) 73
aprotinin (71) 71
blood transfusions (71) 71
blood (69) 69
complications and side effects (68) 68
infant (68) 68
joint surgery (68) 68
pediatrics (67) 67
thrombosis (67) 67
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1846) 1846
German (69) 69
French (26) 26
Spanish (13) 13
Italian (11) 11
Russian (10) 10
Danish (9) 9
Japanese (7) 7
Swedish (7) 7
Chinese (6) 6
Czech (5) 5
Dutch (4) 4
Portuguese (4) 4
Polish (3) 3
Hungarian (2) 2
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 01/2013, Volume 368, Issue 2, pp. 128 - 137
Journal Article
Critical care medicine, ISSN 0090-3493, 06/2010, Volume 38 Suppl, Identification and Prevention of Common Adverse Drug Events in the Intensive Care Unit, Issue 6, pp. S198 - S218
Journal Article
2004, Volume 27, Issue 2, 16
.... Adverse... 
Etamsylate, therapeutic use | Tranexamic acid, therapeutic use | Gestrinone, therapeutic use | Nonsteroidal anti inflammatories, adverse reaction | Contraceptives, adverse reactions | Levonorgestrel, adverse reactions | Progestogens, therapeutic use | Danazol, adverse reactions | Progestogens, adverse reactions | Gestrinone, adverse reactions | Contraceptives, therapeutic use | Intrauterine contraceptive device | Mefenamic acid, adverse reactions | Levonorgestrel, therapeutic use | Antifibrinolytics, adverse reactions | Gonadotropin releasing hormone agonists, adverse r | Nonsteroidal anti inflammatories, therapeutic use | Menorrhagia, treatment | Antifibrinolytics, therapeutic use | Etamsylate, adverse reactions | Benefit risk assessment | Danazol, therapeutic use | Mefenamic acid, therapeutic use | Gonadotropin releasing hormone agonists, therapeut | Tranexamic acid, adverse reactions | Medicine & Public Health | Drug Safety and Pharmacovigilance | Pharmacology/Toxicology | Pharmacology & Pharmacy | Public, Environmental & Occupational Health | Toxicology | Life Sciences & Biomedicine | Science & Technology | Antifibrinolytic Agents - therapeutic use | Contraceptives, Oral, Hormonal - adverse effects | Contraceptives, Oral, Hormonal - therapeutic use | Gestrinone - adverse effects | Risk Assessment | Menorrhagia - drug therapy | Progestins - therapeutic use | Humans | Gonadotropin-Releasing Hormone - adverse effects | Progestins - adverse effects | Treatment Outcome | Antifibrinolytic Agents - adverse effects | Danazol - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Estrogen Antagonists - therapeutic use | Ethamsylate - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Estrogen Antagonists - adverse effects | Ethamsylate - adverse effects | Female | Gestrinone - therapeutic use | Gonadotropin-Releasing Hormone - therapeutic use | Danazol - therapeutic use | Index Medicus
Book Review
The New England journal of medicine, ISSN 1533-4406, 05/2014, Volume 370, Issue 22, pp. 2083 - 2092
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 377, Issue 9779, pp. 1760 - 1769
Journal Article